𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Posttransplantation HBV vaccination: Not an effective strategy in the prophylaxis of HBV recurrence

✍ Scribed by Z. Karasu; Y. Tokat; U.S. Akarca; A. Celebi; C. Arikan; M. Kilic; D. Nart; T. Ozacar; T. Demirbas; S. Erensoy; F. Gunsar; G. Ersoz; Y. Batur

Book ID
117372662
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
158 KB
Volume
38
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Response to an experimental HBV vaccine
Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients
✍ Peter StΓ€rkel; Michel Stoffel; Jan Lerut; Yves Horsmans πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 121 KB

Strategies using lamivudine and hepatitis B immunoglobulins (HBIg) for prevention of hepatitis B virus (HBV) reinfection after liver transplantation (LT) are expensive since life-long treatment is needed. We evaluated the possibility to obtain protective hepatitis B surface antigen (HBsAg) antibody